| 标题： | 整合素RGD受体显像临床应用专家共识（2022版） |
| title： | Expert Consensus on Clinical Application of Integrin RGD Receptor Imaging (2022) |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊断 |
| field： | Diagnosis |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 建议患者进行整合素RGD受体显像诊断疾病的医生。 |
| Guide users： | Doctors who recommend patients to perform integrin RGD receptor imaging to diagnose the disease. |
| 证据分级方法： | 本共识主要纳入两类证据：（1）高水平循证医学证据（1类），专家组一致同意，强力推荐（A）；（2）证据水平稍低（2类），但专家组基本同意，中等推荐（B）。其他等级的证据暂不纳入。 |
| Evidence grading method： | This consensus mainly includes two types of evidence: First, high-level evidence-based medical evidence (Category 1), which is unanimously agreed by the expert group and strongly recommended (A); Second, the level of evidence is slightly lower (Category 2), but the expert group basically agrees, and it is moderately recommended (B). Other levels of evidence will not be currently included. |
| 制定单位： | 中华医学会核医学分会，中国生物物理学会分子影像学分会 |
| Formulating unit： | Chinese Society of Nuclear Medicine, Chinese Society of Molecular |
| 注册时间： | 2022-03-23 |
| Registration time： | |
| 注册编号： | IPGRP-2022CN166 |
| Registration number： | |
| 指南制订的目的： | 基于国际、国内相关临床研究最新进展，本专家共识旨在建立整合素RGD受体显像临床应用的指导原则。 |
| Purpose of the guideline： | Based on the home-and-abroad progress in relevant clinical research, this expert consensus aims to establish principles for clinical application of RGD-based peptides for integrin imaging. |
